DoW Melanoma Research Program Survivorship Research Award
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- May 5, 2026
- Amount
- $2,040,000
- Closes
- Oct 14, 2026 (in 77 days)
Classification and identifiers
- Solicitation number
- HT942526MRPSRA
- Assistance listing (CFDA)
- 12.420
Amount
$2,040,000
Who can apply
About this opportunity
Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Survivorship Research Award addresses the relatively new and underfunded area of melanoma-specific survivorship by supporting a broad range of innovative and impactful research that has the intended outcome of improving the health and well-being of melanoma survivors, their families and/or their care partners in the near term. Proposed studies focusing exclusively on animal models or considering survival only without consideration of quality of life, overall health and/or function are not responsive to this funding opportunity. Distinctive Features: · The application must include at least one melanoma consumer collaborator , defined as a melanoma survivor, family member and/or care partner who can provide lived experience...
Related opportunities
- DoW Melanoma Research Program Melanoma Academy Scholar AwardDefense Health Agency Contracting Activity - DHACACloses in 77 days
- DoW Melanoma Research Program Idea AwardDefense Health Agency Contracting Activity - DHACACloses in 77 days
- DoW Melanoma Research Program Team Science AwardDefense Health Agency Contracting Activity - DHACACloses in 77 days
- DoW Melanoma Research Program Focused Program Award – Rare MelanomasDefense Health Agency Contracting Activity - DHACACloses in 77 days
- DoW Lung Cancer Patient-Centered Outcomes and Survivorship AwardDefense Health Agency Contracting Activity - DHACACloses in 35 days
- DoW Lung Cancer Translational Research AwardDefense Health Agency Contracting Activity - DHACACloses in 35 days